Inside Innovation

Umoja Biopharma, a startup founded last year by Seattle biotech veteran Andy Scharenberg, announced that it has raised $53 million in a recent Series A

Seattle Children’s Hospital, consistently ranked as one of the best children’s hospitals in the U.S., has launched a new endeavor: Seattle Children’s Therapeutics. This research institution

Following its August 2020 pledge to allocate $300 million over the next five years to diversity initiatives, Bristol Myers Squibb announced that $100 million of that

Seattle-based Adaptive Biotechnologies has developed a new type of COVID-19 test that uses a blood sample to determine immune response to the virus. The test

Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform. The company’s “Protein Printing” technology is used to

CBRE named Seattle’s life science industry one of the top in the nation, according to a recent report. Ranked ninth, Seattle brought in record venture

Fueled by unparalleled access to technology and a strong foundation of excellence in research, the life science industry in the Puget Sound region has grown

New census data shows that the number of Seattleites employed in STEM fields has more than doubled over the past decade, hitting almost 89,700 in

The University of Washington has moved up two spots to No. 8 in the latest ranking of Best Global Universities from U.S. News & World

Seattle-based Just – Evotec Biologics received funding from The Bill & Melinda Gates Foundation to seek out and work on new monoclonal antibody (mAb) drugs

Seattle-based biotech company HDT Bio raised $3 million in seed funding to support work on its COVID-19 vaccine candidate that uses a cutting-edge, replicating RNA

Seattle’s Fred Hutchinson Cancer Research Center announced that it is opening a new facility dedicated solely to testing treatments for people who have COVID-19, one